Optune Lua is FDA approved for use with immunotherapy or docetaxel in metastatic stage IV NSCLC post-platinum treatment. The device uses tumor treating fields to disrupt cancer cell division, offering ...
Optune Lua is now approved for use concurrently with immune checkpoint inhibitors or docetaxel in adult patients with metastatic NSCLC who have progressed on or after a platinum-based regimen CE Mark ...
The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on or ...
On Tuesday, the FDA approved NovoCure’s (NASDAQ:NVCR) Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for adult patients with metastatic non-small cell lung cancer (mNSCLC) who ...
Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...
Very often while developing complex systems, engineers have to greatly simplify the task of writing final user space applications. In this case it is desirable to move as far as possible from the ...
A Des Moines microbrewery is a finalist for the best brewpubs across the U.S., and Iowans have a chance to vote it into the top 10. Lua Brewing was nominated for USA TODAY 10Best's Readers' Choice ...
A former Florida teacher has been sentenced to 12 years in prison for sexually abusing students — with a judge denying his request to be castrated instead of serving time. Mark Lua, a former English ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback